Official UK procurement notice
NP31424 Clozapine Medicines · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)·Consortium: 2 public authorities
What is being bought4 lots · detail below
Published requirement descriptionSupply of clozapine medicines (alongside four (4) patient testing routes) to NHS Scotland.
Goods and Services were split into four (4) categories, each of which identified as a “Lot”. The Authority intended to award a single-supplier Framework Agreement per Lot.
Further detail about each Lot is contained in Section II.2.
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 3 suppliers · 3 bids on the busiest of 2 lots (1.0 per place) · 1 appointed
Lots and requirements (4)Procurement structure
4 lots · 3 with a published value · same evaluation weights on every lotLot #1Clozapine Tablets (Core)AwardedRenewalPublished value£4,026,980
Supply of Clozapine Tablets (Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.
Lot #2Clozapine Orodispersible Tablets Sugar Free (Non-Core)CancelledRenewalPublished value£334,525
Supply of Clozapine Orodispersible Tablets Sugar Free (Non Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intended to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.
Lot #3Clozapine Oral Suspension Sugar Free (Non-Core)CancelledRenewalPublished value£679,100
Supply of Clozapine Clozapine Oral Suspension Sugar Free (Non-Care), alongside three (3) patient testing routes, to NHS Scotland. The Authority intended to award this Lot as
a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.
Lot #4Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)AwardedRenewalLot estimate not published
Supply of Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core), alongside one (1) patient testing route, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (6)
- Technical (Services) -- Central Laboratory Testing: 12%
- Technical (Services) -- Local Laboratory Testing: 12%
- Technical (Services) -- Near Patient Testing (General): 12%
- Technical (Services) -- Training, Educational, and Support Materials: 6%
- Technical (Services) -- Implementation Plan: 18%
- price: 40%
Published award criteria (6)
- Technical (Services) -- Central Laboratory Testing: 12
- Technical (Services) -- Local Laboratory Testing: 12
- Technical (Services) -- Near Patient Testing (General): 12
- Technical (Services) -- Training, Educational, and Support Materials: 6
- Technical (Services) -- Implementation Plan: 18
- Price: 40
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.
AND
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
(e) Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
- Price carries 40 of 100 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
- “NP31424 Clozapine Medicines” is a framework: the contest is a place on its panel, up to 3 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 5 Jul 2024, 14:34 BST
- Last source update
- 28 Feb 2025, 11:30 GMT
- Award evaluation window
- 5 Aug 2024 – …
- FTS notice number
2025/S 000-007495- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-047b2cFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) covers the thirty-six (36) month Framework duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:781676)
How it was run
Official notice- Appointment period ends
- 5 Aug 2024, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 5 Aug 2024, 12:00 BST
Timeline
5 Aug 2024 → 28 Feb 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown5 Aug 2024, 12:00 BST
- Bids opened5 Aug 2024, 12:00 BST
- Notice published28 Feb 2025, 11:30 GMT
Notice history
2 events · 3 releases on Find a Tender · since 28 Oct 2024- Status changed to complete28 Oct 2024, 13:59 GMT
- Buyer details updated28 Oct 2024, 13:59 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast4 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 2 of these contracts carry the same published figure, £4,309,695, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Clozapine Tablets (Core)
- Signed
- 4 Oct 2024
- Value
- ceiling above
- Status
- active
Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)
- Signed
- 4 Oct 2024
- Value
- £7,901
- Status
- active
Clozapine Tablets (Core)
- Signed
- 4 Oct 2024
- Value
- ceiling above
- Status
- active
Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)
- Signed
- 4 Oct 2024
- Value
- £7,901
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Clozapine Tablets (Core) | 3bids · 3 electronic · 3 from abroad | 0 | — | — |
| 4 · Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core) | 3bids · 3 electronic · 3 from abroad | 0 | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeDispute resolution & review bodies
- Sheriff Court HouseReview body
- Sherriff Court HouseReview body
Framework contractors & participating bidders
1 commercial party on the notice- Viatris UK Healthcare LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.